SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 3 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,532,003 | -9.2% | 200,653 | -1.0% | 0.06% | +5.2% |
| Q2 2023 | $6,091,749 | -44.9% | 202,653 | -33.6% | 0.06% | -49.1% |
| Q1 2023 | $11,053,012 | -52.7% | 305,079 | -53.5% | 0.11% | -55.3% |
| Q4 2022 | $23,389,960 | -1.7% | 655,732 | -6.7% | 0.26% | -8.6% |
| Q3 2022 | $23,790,000 | +33.5% | 702,808 | +14.0% | 0.28% | +36.1% |
| Q2 2022 | $17,826,000 | -15.3% | 616,375 | -5.4% | 0.20% | +7.3% |
| Q1 2022 | $21,052,000 | +16.9% | 651,355 | +5.4% | 0.19% | +34.5% |
| Q4 2021 | $18,012,000 | +16.6% | 617,701 | +6.7% | 0.14% | +17.4% |
| Q3 2021 | $15,444,000 | -38.6% | 579,073 | -29.1% | 0.12% | -34.2% |
| Q2 2021 | $25,147,000 | +24.8% | 816,731 | +6.1% | 0.18% | +21.1% |
| Q1 2021 | $20,146,000 | – | 769,523 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |